enVVeno Medical Corp

NVNO

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001661053

SEC filings (opens in a new tab)

In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding enVVeno Medical Corp changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of NVNO: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Q4 2024	Change
Holders	36	35	−1
Shares	5.21M	4.26M	−946.9K (−18.2%)
Value	$17.5M	$12.9M	−$4.62M (−26.4%)

New holders (10)

Institutions that held enVVeno Medical Corp at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to NVNO in Q4 2024
Institution	Shares	Value	% of portfolio
JPMorgan Chase & Co	270,041	$815.5K	0.00%
Marshall Wace, LLP	48,818	$147.4K	0.00%
Squarepoint Ops LLC	47,894	$144.6K	0.00%
Quadrature Capital Ltd	39,229	$118.9K	0.00%
Virtu Financial LLC	28,533	$86.0K	0.00%
National Bank of Canada	20,000	$60.4K	0.00%
Jane Street Group, LLC	18,502	$55.9K	0.00%
Sanctuary Advisors, LLC	12,000	$39.4K	0.00%
Group One Trading, L.P.	284	$858	0.00%
SBI Securities Co., Ltd.	6	$18	0.00%

Sold out (11)

Institutions that held enVVeno Medical Corp at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of NVNO in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Perceptive Advisors LLC	694,315	$2.33M
ADAR1 Capital Management, LLC	348,263	$1.17M
Heights Capital Management, Inc	141,477	$475.4K
Corsair Capital Management, L.P.	116,000	$389.8K
Hudson Bay Capital Management LP	93,150	$313.0K
Maven Securities LTD	87,880	$295.3K
Susquehanna International Group, LLP	19,119	$64.2K
Arthur M. Cohen & Associates, LLC	14,000	$44.8K
Dunhill Financial, LLC	5,000	$16.8K
Royal Bank of Canada	1,490	$5.00K
Simplex Trading, LLC	288	$0